Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of earnings (loss) per share basic and diluted

	Three Months ended September 30,				Nine Months ended September 30,
	2013		2012		2013		2012
	(in thousands, except for per share data)
Numerator:

Net Income	$	40,604	$	45,483	$	34,775	$	56,645

Denominator:

Weighted average common stock shares outstanding - Basic	52,303		51,444		51,994		51,246
Assumed exercise of equity awards	1,209		1,179		1,166		1,217
Weighted average common stock shares outstanding - Diluted	53,512		52,623		53,160		52,463

Net Income per common share:
Basic	$	0.78	$	0.88	$	0.67	$	1.11
Diluted	$	0.76	$	0.86	$	0.65	$	1.08

Summary of common stock equivalent excluded from the computation of diluted earnings (loss) per share because the awards were antidilutive

	Three Months ended September 30,		Nine Months ended September 30,
	2013	2012	2013	2012
	(in thousands)
Stock options	—	83	522	90
Deferred stock	—	—	58	—
Restricted stock	1,031	607	1,494	664
Convertible notes (1)	10,943	10,943	10,943	10,943
Warrants	10,943	10,943	10,943	10,943

(1) In March 2011, the Company entered into a financing transaction which included the sale of convertible notes, purchase of convertible note hedges, and the sale of warrants. These weighted common stock equivalents were excluded from the computation of diluted earnings per share because their conversion price of $7.88 per share for the convertible notes and $10.00 for the warrants exceeded the average market price of the common stock during these periods, and the effect of their inclusion would be antidilutive. However, these securities could be dilutive in future periods. The convertible note hedges will always be antidilutive and, therefore, will have no effect on diluted earnings per share.